Your email has been successfully added to our mailing list.

×
0.00800000000000001 0.00800000000000001 0 -0.0089599999999999 -0.016 -0.00399999999999992 -0.0150399999999999 -0.0057599999999999
Stock impact report

Moleculin Bio up 6% premarket on WP1122 deal for COVID-19 [Seeking Alpha]

Moleculin Biotech, Inc. (MBRX) 
Last moleculin biotech, inc. earnings: 8/16 05:35 pm Check Earnings Report
US:NASDAQ Investor Relations: moleculin.com/investors
Company Research Source: Seeking Alpha
Moleculin Biotech (NASDAQ:MBRXenteredThe announcement follows on the heels of the discovery by researchers at the Goethe University in Frankfurt that 2 deoxy-D-glucose (2-DG, and the active compound in WP1122) inhibited SARS-CoV–2 replication in susceptible cell lines.Shares are up6% Show less Read more
Impact Snapshot
Event Time:
MBRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for MBRX alerts
Opt-in for
MBRX alerts

from News Quantified
Opt-in for
MBRX alerts

from News Quantified